Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Ross-Innes, Caryn; Stark, Rory; Teschendorff, Andrew E; Holmes, Kelly-Ann; Ali, Raza; Dunning, Mark; Brown, Gordon D; Gojis, Ondrej; Ellis, Ian O; Green, Andrew R; Ali, Simak; Chin, Suet-Feung; Palmieri, Carlo; Caldas, Carlos; Carroll, Jason

View / Open Files

Accepted version (PDF, 1Mb)

Authors

Ross-Innes, Caryn

Stark, Rory

Teschendorff, Andrew E

Holmes, Kelly-Ann

Ali, Raza

Dunning, Mark

Brown, Gordon D

Publication Date

2012-01-04

Journal Title

Nature

ISSN

0028-0836

Volume

481

Issue

7381

Pages

389-393

Language

eng

Type

Article

This Version

Physical Medium

Electronic

Metadata

Show full item record

Citation

Ross-Innes, C., Stark, R., Teschendorff, A. E., Holmes, K., Ali, R., Dunning, M., Brown, G. D., et al. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.. Nature, 481 (7381), 389-393. https://doi.org/10.1038/nature10730

Keywords

Cell Line, Tumor, Humans, Breast Neoplasms, Neoplasm Metastasis, Tamoxifen, Receptors, Estrogen, Prognosis, Treatment Outcome, Survival Analysis, Gene Expression Regulation, Neoplastic, Base Sequence, Regulatory Sequences, Nucleic Acid, Protein Binding, Drug Resistance, Neoplasm, Female, Hepatocyte Nuclear Factor 3-alpha

Identifiers

External DOI: https://doi.org/10.1038/nature10730

This record's URL: https://www.repository.cam.ac.uk/handle/1810/268192

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved